Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)
NCT01218360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71
Last updated 2015-03-19
Summary
This is an observational study to determine the prevalence of moderate to severe Crohn's disease (CD) among patients with active CD and to evaluate existing therapeutic trends in a standard clinical practice.
Conditions
- Crohn Disease
Interventions
- DRUG
-
Physician standard-of-care
Participants will be treated according to their physician's routine practice and the respective Summary of Product Characteristics (SmPC).
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2015-01-31
- Completion
- 2015-01-31
More Related Trials
-
A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease
NCT00615199 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Evaluation of a Scoring System in Patients Newly Diagnosed With Crohn's Disease
NCT02193048 ·Status: COMPLETED
-
A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease
NCT04102111 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
NCT06430801 ·Status: RECRUITING ·Phase: PHASE3
-
Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease
NCT01860846 ·Status: COMPLETED
-
Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis
NCT03169894 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
NCT01369329 ·Status: COMPLETED ·Phase: PHASE3
-
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease
NCT03395184 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease
NCT02531113 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease
NCT00562887 ·Status: TERMINATED ·Phase: PHASE2
-
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
NCT01393626 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease
NCT05471492 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis
NCT04877990 ·Status: COMPLETED ·Phase: PHASE2
-
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
NCT01536418 ·Status: TERMINATED ·Phase: PHASE3
-
Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease
NCT00101946 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease
NCT03854305 ·Status: COMPLETED ·Phase: PHASE2
-
Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)
NCT01349920 ·Status: COMPLETED
-
Optimizing Cimzia in Crohn's Patients
NCT01024647 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease
NCT02065570 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
NCT02877134 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Data Analysis in Crohn's Disease
NCT01363427 ·Status: COMPLETED
-
Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease
NCT07078994 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
NCT02394028 ·Status: COMPLETED ·Phase: PHASE3
-
Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease
NCT04283864 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease
NCT00446433 ·Status: COMPLETED ·Phase: PHASE2